Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group
- PMID: 1433739
Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group
Abstract
Objective: To evaluate the contribution of mild to moderate hypertension to progressive loss of renal function by analysis of renal function data from the Multiple Risk Factor Intervention Trial.
Design: The cohort of men with mild to moderate hypertension (baseline diastolic blood pressure > or = 90 mm Hg), randomized to a special intervention (SI) group or usual care (UC) group, were examined for change in renal function based on individual reciprocal creatinine slopes over an average of 7 years' follow-up as the outcome measure. Contribution of blood pressure control during follow-up, age, race, and blood pressure at entry were assessed.
Participants: The cohort of 5524 (463 black, 5061 nonblack) hypertensive men receiving no therapy at entry provided the data for the present analysis.
Results: Blood pressure control was similar for black and white participants, but significant decline in reciprocal creatinine slope was found for black men (mean slope, -0.0090 +/- 0.0013 dL/mg/y) compared with white men (+0.0018 +/- 0.0004 dL/mg/y) (P < .001 for difference between blacks and whites). Decline in renal function was also greater among individuals with elevated systolic (P < .001) as well as diastolic blood pressure (P < .001), and older individuals (P < .001). No difference between the SI and UC groups was seen in reciprocal creatinine slopes, but in both groups combined, treatment that maintained diastolic blood pressure below an average value of 95 mm Hg was associated with stable or improving renal function, whereas participants whose blood pressure remained 95 mm Hg or greater continued to decline at -0.0013 +/- 0.0009 dL/mg/y (P = .007 for difference). Separate examination of the subset of black men (n = 463) failed to show such a difference.
Conclusions: Effective blood pressure control was associated with stable or improving renal function in nonblacks but not in blacks. These findings emphasize the importance of blood pressure control to maintain adequate renal function in hypertensive white men and raise important questions about the relationship of pressure reduction and renal function change in blacks.
Comment in
-
Can we prevent end-stage renal disease due to hypertension or to diabetes mellitus?JAMA. 1992 Dec 2;268(21):3119-20. JAMA. 1992. PMID: 1433743 No abstract available.
-
Renal disease in hypertensive blacks: MRFIT.JAMA. 1993 May 26;269(20):2629; author reply 2630. doi: 10.1001/jama.269.20.2629b. JAMA. 1993. PMID: 8487443 No abstract available.
-
Renal disease in hypertensive blacks: MRFIT.JAMA. 1993 May 26;269(20):2629-30. doi: 10.1001/jama.1993.03500200043029. JAMA. 1993. PMID: 8487444 No abstract available.
Similar articles
-
Ethnicity and renal disease: lessons from the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study.Am J Kidney Dis. 1993 Apr;21(4 Suppl 1):31-40. doi: 10.1016/s0272-6386(12)80859-6. Am J Kidney Dis. 1993. PMID: 8465834 Clinical Trial.
-
Racial differences in the renal response to blood pressure lowering during chronic angiotensin-converting enzyme inhibition: a prospective double-blind randomized comparison of fosinopril and lisinopril in older hypertensive patients with chronic renal insufficiency.Am J Kidney Dis. 1997 Jun;29(6):897-906. doi: 10.1016/s0272-6386(97)90464-9. Am J Kidney Dis. 1997. PMID: 9186076 Clinical Trial.
-
Renal function during antihypertensive treatment.Lancet. 1995 Mar 25;345(8952):749-51. doi: 10.1016/s0140-6736(95)90638-x. Lancet. 1995. PMID: 7891485
-
Hypertension-related renal injury: a major contributor to end-stage renal disease.Am J Kidney Dis. 1993 Jul;22(1):164-73. doi: 10.1016/s0272-6386(12)70183-x. Am J Kidney Dis. 1993. PMID: 8322780 Review.
-
The kidney in the hypertensive black.Ethn Health. 1996 May;1(2):145-51. doi: 10.1080/13557858.1996.9961781. Ethn Health. 1996. PMID: 9395558 Review.
Cited by
-
Hypertension and kidney disease: a deadly connection.Curr Cardiol Rep. 2006 Nov;8(6):411-7. doi: 10.1007/s11886-006-0098-7. Curr Cardiol Rep. 2006. PMID: 17059792 Review.
-
Evidence-based practice guideline for the treatment of CKD.Clin Exp Nephrol. 2009 Dec;13(6):537-66. doi: 10.1007/s10157-009-0237-8. Clin Exp Nephrol. 2009. PMID: 19960305 No abstract available.
-
Renin-angiotensin-aldosterone system in the elderly: rational use of aliskiren in managing hypertension.Clin Interv Aging. 2009;4:137-51. doi: 10.2147/cia.s3216. Epub 2009 May 14. Clin Interv Aging. 2009. PMID: 19503776 Free PMC article. Review.
-
Novel Treatment of Hepatitis C Virus Infection for Patients with Renal Impairment.J Clin Transl Hepatol. 2016 Dec 28;4(4):320-327. doi: 10.14218/JCTH.2016.00032. Epub 2016 Dec 26. J Clin Transl Hepatol. 2016. PMID: 28097101 Free PMC article. Review.
-
Potential effects of MYH9-associated nephropathy on dialysis and kidney transplant outcomes.Semin Dial. 2010 May-Jun;23(3):244-7. doi: 10.1111/j.1525-139X.2010.00721.x. Epub 2010 May 10. Semin Dial. 2010. PMID: 20492585 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical